Word

ELEVIDYS

Status

Registered

Status Code

700

Status Date

Tuesday, April 25, 2023

Serial Number

88886693

Registration Number

7037471

Registration Date

Tuesday, April 25, 2023

Mark Type

4000

Filing Date

Friday, April 24, 2020

Published for Opposition

Tuesday, July 14, 2020

Trademark Owner History

Sarepta Therapeutics, Inc. - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Trademark Events

Apr 25, 2023

Notice Of Registration Confirmation Emailed

Apr 25, 2023

Registered-Principal Register

Mar 23, 2023

Notice Of Acceptance Of Statement Of Use E-Mailed

Mar 22, 2023

Allowed Principal Register - Sou Accepted

Mar 20, 2023

Statement Of Use Processing Complete

Mar 14, 2023

Use Amendment Filed

Mar 14, 2023

Teas Statement Of Use Received

Mar 7, 2023

Notice Of Approval Of Extension Request E-Mailed

Mar 6, 2023

Sou Extension 5 Granted

Feb 17, 2023

Sou Extension 5 Filed

Mar 3, 2023

Case Assigned To Intent To Use Paralegal

Feb 17, 2023

Teas Extension Received

Aug 26, 2022

Notice Of Approval Of Extension Request E-Mailed

Aug 24, 2022

Sou Extension 4 Granted

Aug 24, 2022

Sou Extension 4 Filed

Aug 24, 2022

Teas Extension Received

Feb 19, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 17, 2022

Sou Extension 3 Granted

Feb 17, 2022

Sou Extension 3 Filed

Feb 17, 2022

Teas Extension Received

Aug 28, 2021

Notice Of Approval Of Extension Request E-Mailed

Aug 26, 2021

Sou Extension 2 Granted

Aug 26, 2021

Sou Extension 2 Filed

Aug 26, 2021

Teas Extension Received

Feb 23, 2021

Notice Of Approval Of Extension Request E-Mailed

Feb 19, 2021

Sou Extension 1 Granted

Feb 19, 2021

Sou Extension 1 Filed

Feb 19, 2021

Teas Extension Received

Sep 8, 2020

Noa E-Mailed - Sou Required From Applicant

Jul 14, 2020

Official Gazette Publication Confirmation E-Mailed

Jul 14, 2020

Published For Opposition

Jun 24, 2020

Notification Of Notice Of Publication E-Mailed

Jun 5, 2020

Approved For Pub - Principal Register

Jun 3, 2020

Assigned To Examiner

May 5, 2020

New Application Office Supplied Data Entered

Apr 28, 2020

New Application Entered